News and Breakthroughs
Research scientists at Cedars-Sinai continually advance a new understanding of diseases, as well as new ideas and technologies for prevention and treatment. This diligence generates a steady stream of news about their transformational achievements and their benefits to healthcare.
Cedars-Sinai is now home to the Center for Medicine, Holocaust and Genocide Studies (MHGS)—an international hub for the interdisciplinary study of the activities of medical professionals before, during and after the Holocaust, other genocides and episodes of mass violence.
Patients with inflammatory bowel disease (IBD) who received the COVID-19 vaccine from Johnson & Johnson produced significantly lower levels of antibodies against the SARS-CoV-2 virus than those who received the Pfizer-BioNTech or Moderna vaccines, according to a study led by Cedars-Sinai.
Cedars-Sinai investigators have made significant progress in identifying the mechanisms behind idiopathic pulmonary fibrosis, a deadly disease that scars the lungs and impairs breathing.